tiprankstipranks
Advertisement
Advertisement

RPRX Stock Latest News

Royalty Pharma buys royalty interest in AstraZeneca cliramitug for $125M upfront
The FlyRoyalty Pharma buys royalty interest in AstraZeneca cliramitug for $125M upfront
16h ago
AZN
RPRX
Royalty Pharma price target raised to $65 from $50 at TD Cowen
PremiumThe Fly
Royalty Pharma price target raised to $65 from $50 at TD Cowen
10d ago
RPRX
Royalty Pharma Shareholders Back Board, Pay and Flexibility
PremiumCompany Announcements
Royalty Pharma Shareholders Back Board, Pay and Flexibility
2M ago
8K
RPRX
Royalty Pharma Secures New $1.8 Billion Credit Facility
PremiumCompany Announcements
Royalty Pharma Secures New $1.8 Billion Credit Facility
2M ago
8K
RPRX
Royalty Pharma price target raised to $64 from $63 at Morgan Stanley
PremiumThe Fly
Royalty Pharma price target raised to $64 from $63 at Morgan Stanley
3M ago
RPRX
Royalty Pharma price target raised to $58 from $50 at JPMorgan
PremiumThe FlyRoyalty Pharma price target raised to $58 from $50 at JPMorgan
3M ago
RPRX
Royalty Pharma price target raised to $66 from $50 at Citi
Premium
The Fly
Royalty Pharma price target raised to $66 from $50 at Citi
3M ago
RPRX
Royalty Pharma’s Earnings Call Signals Confident Growth
Premium
Company Announcements
Royalty Pharma’s Earnings Call Signals Confident Growth
3M ago
RPRX
Royalty Pharma price target raised to $57 from $51 at UBS
PremiumThe Fly
Royalty Pharma price target raised to $57 from $51 at UBS
3M ago
RPRX
Royalty Pharma: Leveraged Biopharma Catalysts and De-Risked Royalty Growth Support Further Upside
PremiumRatings
Royalty Pharma: Leveraged Biopharma Catalysts and De-Risked Royalty Growth Support Further Upside
3M ago
RPRX
Royalty Pharma Expands Daraxonrasib Royalty Stake After Milestone
PremiumCompany Announcements
Royalty Pharma Expands Daraxonrasib Royalty Stake After Milestone
3M ago
8K
RPRX
Royalty Pharma price target raised to $63 from $61 at Morgan Stanley
PremiumThe Fly
Royalty Pharma price target raised to $63 from $61 at Morgan Stanley
3M ago
RPRX
Royalty Pharma reports co-funding agreement with Johnson & Johnson for JNJ-4804
PremiumThe FlyRoyalty Pharma reports co-funding agreement with Johnson & Johnson for JNJ-4804
4M ago
JNJ
RPRX
Zymeworks price target raised to $48 from $33 at Evercore ISI
Premium
The Fly
Zymeworks price target raised to $48 from $33 at Evercore ISI
5M ago
RPRX
ZYME
Royalty Pharma appoints Kenneth Sun as Senior Vice President, Head of Asia
Premium
The Fly
Royalty Pharma appoints Kenneth Sun as Senior Vice President, Head of Asia
5M ago
RPRX
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
PremiumThe Fly
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
5M ago
ONC
JAZZ
Royalty Pharma price target raised to $50 from $45 at TD Cowen
PremiumThe Fly
Royalty Pharma price target raised to $50 from $45 at TD Cowen
5M ago
RPRX
The Week That Was, The Week Ahead: Macro and Markets, Feb. 15
PremiumMarket News
The Week That Was, The Week Ahead: Macro and Markets, Feb. 15
5M ago
J
W
Royalty Pharma Earnings Call Balances Strength And Risk
PremiumCompany Announcements
Royalty Pharma Earnings Call Balances Strength And Risk
5M ago
RPRX
Royalty Pharma price target raised to $51 from $45 at Goldman Sachs
PremiumThe FlyRoyalty Pharma price target raised to $51 from $45 at Goldman Sachs
5M ago
RPRX
Royalty Pharma price target raised to $61 from $56 at Morgan Stanley
Premium
The Fly
Royalty Pharma price target raised to $61 from $56 at Morgan Stanley
5M ago
RPRX
Royalty Pharma sees FY26 portfolio receipts $3.275B-3.425B
Premium
The Fly
Royalty Pharma sees FY26 portfolio receipts $3.275B-3.425B
5M ago
RPRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >